Francisco Marín Selected Research

Peripheral Arterial Disease

7/2021	Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.
11/2015	The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Marín Research Topics

Disease

112	Atrial Fibrillation 09/2023 - 05/2002
56	Hemorrhage 07/2023 - 02/2008
43	Stroke (Strokes) 01/2023 - 01/2005
33	Acute Coronary Syndrome 06/2023 - 12/2007
29	Myocardial Infarction 06/2023 - 08/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2003
16	Heart Failure 02/2023 - 02/2003
16	Thrombosis (Thrombus) 07/2021 - 03/2004
14	Inflammation (Inflammations) 01/2023 - 07/2003
13	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2015 - 06/2006
11	Hypertension (High Blood Pressure) 02/2023 - 05/2003
10	Coronary Artery Disease (Coronary Atherosclerosis) 09/2023 - 12/2007
9	Ischemic Stroke 06/2023 - 01/2008
8	Embolism (Embolus) 01/2023 - 04/2009
7	COVID-19 04/2024 - 01/2021
7	Thromboembolism 09/2017 - 02/2008
6	Fibrosis (Cirrhosis) 01/2023 - 05/2003
5	Atherosclerosis 09/2023 - 12/2003
5	Dyspnea (Shortness of Breath) 05/2023 - 05/2004
4	ST Elevation Myocardial Infarction 03/2024 - 04/2013
4	Renal Insufficiency (Renal Failure) 06/2023 - 01/2021
4	Chronic Kidney Failure (Chronic Renal Failure) 06/2023 - 04/2009
4	Coronary Disease (Coronary Heart Disease) 05/2023 - 08/2005
4	Vascular Diseases (Vascular Disease) 02/2023 - 07/2012
4	Heart Diseases (Heart Disease) 01/2023 - 08/2005
4	Venous Thromboembolism 09/2022 - 05/2008
4	Sepsis (Septicemia) 07/2022 - 01/2020
4	Venous Thrombosis (Deep-Vein Thrombosis) 07/2021 - 05/2008
4	Thrombophilia 01/2018 - 05/2008
4	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014 - 08/2005
3	Frailty 03/2024 - 01/2019
3	Chest Pain (Chest Pains) 05/2023 - 08/2012
3	Transient Ischemic Attack 01/2023 - 07/2017
3	Diabetes Mellitus 02/2022 - 03/2014
3	Obesity 01/2021 - 11/2017
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2020 - 01/2017
3	Anemia 01/2019 - 09/2008
2	Non-ST Elevated Myocardial Infarction 03/2024 - 06/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2023 - 11/2017
2	Atrial Remodeling 01/2023 - 01/2006
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Peripheral Arterial Disease 07/2021 - 11/2015
2	Hemorrhagic Stroke 01/2020 - 03/2016

Drug/Important Bio-Agent (IBA)

32	AnticoagulantsIBA 09/2022 - 11/2002
32	Vitamin K FDA Link 09/2022 - 04/2012
28	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
16	omega-Chloroacetophenone (Mace)IBA 06/2023 - 02/2008
10	RivaroxabanIBA 01/2023 - 06/2015
9	pro-brain natriuretic peptide (1-76)IBA 12/2017 - 11/2003
8	Troponin T (Troponin T1)IBA 05/2023 - 12/2009
8	C-Reactive ProteinIBA 01/2021 - 08/2005
8	von Willebrand FactorIBA 01/2018 - 01/2005
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 05/2004
7	TroponinIBA 04/2024 - 10/2009
7	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 11/2008
6	Clopidogrel (Plavix)FDA Link 06/2023 - 11/2008
6	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2013
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2010
6	AcenocoumarolIBA 03/2018 - 11/2015
6	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2003
6	LipidsIBA 11/2017 - 08/2005
6	Factor XIII (Coagulation Factor XIII)IBA 09/2010 - 08/2002
5	TicagrelorIBA 06/2023 - 01/2018
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021 - 06/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2006
4	CollagenIBA 01/2023 - 06/2008
4	CreatinineIBA 11/2021 - 11/2012
4	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2018
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2019 - 01/2012
4	Dabigatran FDA Link 01/2018 - 06/2012
4	FibrinIBA 01/2018 - 08/2009
4	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 01/2004
4	GadoliniumIBA 12/2010 - 06/2008
4	Prothrombin (Factor II)IBA 05/2008 - 07/2003
3	CholesterolIBA 09/2023 - 08/2009
3	Factor Xa InhibitorsIBA 01/2023 - 01/2021
3	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2021 - 07/2003
3	Growth Differentiation Factor 15IBA 12/2020 - 03/2012
3	apixabanIBA 01/2018 - 06/2015
3	Cystatin CIBA 04/2015 - 11/2012
3	P-SelectinIBA 08/2014 - 09/2004
3	Trinitrotoluene (TNT)IBA 01/2013 - 12/2010
3	fibrin fragment D (D-dimer)IBA 06/2011 - 08/2009
3	Fibrinogen (Factor I)FDA Link 09/2010 - 09/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2010 - 08/2005
3	E-SelectinIBA 03/2004 - 07/2003
2	Particulate MatterIBA 07/2023 - 11/2020
2	N(4)-oleylcytosine arabinosideIBA 09/2022 - 03/2016
2	Troponin IIBA 01/2021 - 01/2013
2	Galectin 3 (LGALS3)IBA 01/2019 - 12/2017

Therapy/Procedure

72	Therapeutics 09/2023 - 07/2003
17	Stents 07/2019 - 03/2007
14	Percutaneous Coronary Intervention 03/2019 - 01/2006
7	Electric Countershock (Cardioversion) 01/2020 - 06/2006
4	Drug Therapy (Chemotherapy) 07/2023 - 07/2003
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 01/2006
3	Thrombolytic Therapy 09/2010 - 08/2002
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Critical Care (Surgical Intensive Care) 01/2019 - 02/2014